Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
!!Link opens in a new tab
!!Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Leveraging conformational ensembles in allosteric drug discovery
Ruth Nussinov
*
, Clil Regev
, Hyunbum Jang
*
Corresponding author for this work
Human Molecular Genetics Biochemistry
Leidos Inc
National Institutes of Health
Cancer Innovation Laboratory
Computational Structural Biology Section
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Leveraging conformational ensembles in allosteric drug discovery'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Conformational Ensemble
100%
Biomolecular Condensates
100%
Allosteric Drug Discovery
100%
Drug Development
50%
Drug Discovery
50%
Drug Action
50%
Mammalian Target of Rapamycin (mTOR)
50%
Signaling Network
50%
Molecular Dynamics Simulation
50%
Dogma
50%
Active State
50%
Traceback
50%
Oncogenic mutant
50%
Model Limitations
50%
Dynamic Ensemble
50%
Allosteric Drug Design
50%
Heterogeneous Dynamics
50%
Ensemble-based Approach
50%
Targetable
50%
Cryptic Pockets
50%
Exosite
50%
Promising Therapeutics
50%
Inactive State
50%
Dynamic Conformational Ensemble
50%
Induced-fit Model
50%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
50%
Biochemistry, Genetics and Molecular Biology
Conformational Ensembles
100%
Drug Development
100%
Carcinogenesis
20%
Epidermal Growth Factor Receptor
20%
Mechanistic Target of Rapamycin
20%
Drug Mechanism
20%
Exosite
20%
Induced Fit Model
20%
Chemistry
Drug Discovery
100%
Statistical Ensemble
100%
Epidermal Growth Factor
16%
Molecular Dynamics Simulation
16%
Sirolimus
16%